WebMD - July 27, 2020
Oladimeji Oki, M.D., discusses the social, economic, and quality-of-life factors that may account for higher rates of COVID-19 cases and mortality among Hispanics. Dr. Oki is assistant professor of family and social medicine at Einstein and a family medicine physician at Montefiore Health System.
Dr. Oki's Profile
Science News - July 23, 2020
Marla Keller, M.D., Will Southern, M.D., M.S., and Shitij Arora, M.D., are co-authors on a study that finds a blood test can help physicians determine which hospitalized patients with COVID-19 can benefit from steroids. Dr. Keller is vice chair of research in the department of medicine; Dr. Southern is chief of hospital medicine; and Dr. Arora is associate professor of medicine and a hospitalist at Montefiore.
Additional coverage includes USA Today, LoHud, Fox News, US News & World Report (via HealthDay), Daily Mail, LabPulse
Dr. Keller's Profile
WSJ - July 14, 2020
Nir Barzilai, M.D., says varying rates of protein level changes are among the biological differences in how men and women age. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein and an endocrinologist at Montefiore.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
Medscape - July 14, 2020
Michal Melamed, M.D., discusses her editorial in the Clinical Journal of the American Society of Nephrology that advises nephrologists take extra precautions with their high risk patients, such as home dialysis, in light of the COVID-19 pandemic. Dr. Melamed is associate professor of medicine and of epidemiology & population health at Einstein and a nephrologist at Montefiore.
Dr. Melamed's ProfileMore coverage on Dr. Melamed
The City - July 14, 2020
Caterina Minniti, M.D., comments on the challenges faced by patients with sickle-cell disease during the COVID-19 pandemic, including the disease's side effects that may put people at higher risk for complications and death. Dr. Minniti is professor of clinical medicine and of pediatrics at Einstein and director of the Sickle Cell Center for Adults at Montefiore.
Dr. Minniti's Profile
The New York Times - June 27, 2020
A column by Nicholas Kristof hails positive examples of Hispanic community members helping one another in difficult times, including the COVID-19 pandemic. He notes that Carmen Isasi, M.D., Ph.D., who studies LatinX populations, has seen Spanish-speaking churches in New York City offering food for those in need. Dr. Isasi is associate professor of epidemiology & population health and of pediatrics.
Dr. Isasi's Profile
Modern Healthcare - June 19, 2020
Will Southern, M.D., M.S., and Shitij Arora, M.B.B.S., comment on an unpublished U.K. study that found the steroid dexamethasone helped patients with severe COVID-19, a finding consistent with their upcoming paper on steroid use in Montefiore's hospitalized patients. Dr. Southern is professor of medicine and chief of the division of hospital medicine at Einstein and Montefiore. Dr. Arora is associate professor of medicine at Einstein and an internist at Montefiore.
Additional coverage includes WIRED
Dr. Southern's ProfileMore coverage on Dr. Southern
Wired - June 17, 2020
Priya Nori, M.D., explains that the FDA's decision to revoke its Emergency Use Authorization for hydroxychloroquine to treat COVID-19 will have little impact on clinicians, many of whom had already shied away from using the antimalarial drug. Dr. Nori is assistant professor of medicine at Einstein and medical director of the antibiotic stewardship program at Montefiore Health System.
Dr. Nori's ProfileMore coverage on Dr. Nori
US News & World Report - June 16, 2020
Nir Barzilai, M.D., co-authors an op-ed that calls for a national campaign to combat chronic disease and fund research on drugs that target age-related disease—measures that could help protect vulnerable populations from the ravages of COVID-19. Dr. Barzilai is the Ingeborg and Ira Leon Rennert Chair of Aging Research and director of the Institute for Aging Research at Einstein and an endocrinologist at Montefiore.
Dr. Barzilai's ProfileMore coverage on Dr. Barzilai
WSJ - June 10, 2020
Harris Goldstein, M.D., and Brian Pelowski discuss Einstein's success in transforming a lab to provide viral transport medium after the New York City Economic Development Corporation requested the college's assistance for its initiative to produce 50,000 COVID-19 testing kits each week. Dr. Goldstein is associate dean for scientific resources and Mr. Pelowski is assistant dean for scientific operations.
Additional coverage of the initiative includes CBS NewYork, US News & World Report, NBC 4 New York, ABC7NewYork, PIX11, AMNewYork, The Staten Island Advance, Patch, Gothamist, WCBS880, The Daily News, and The New York Post.
Dr. Goldstein's ProfileMore coverage on Dr. Goldstein
Medscape - June 9, 2020
Gordon Tomaselli, M.D., discusses the potential use of a non-invasive magnetic stimulation technique to treat ventricular tachycardia, the accelerated or irregular heart rhythm condition that causes about 300,000 deaths annually in the United States. Dr. Tomaselli is the Marilyn and Stanley M. Katz Dean at Einstein and executive vice president and chief academic officer at Montefiore Medicine.
Dr. Tomaselli's ProfileMore coverage on Dr. Tomaselli
The New York Times - June 9, 2020
Philip Ozuah, M.D., Ph.D., recounts painful personal experiences of racism, addresses how the COVID-19 pandemic disproportionately hurt minorities, and shares his hopes for societal change in a New York Times op-ed. Dr. Ozuah is president and CEO of Montefiore Medicine.
Additional coverage on this story includes MSNBC
Dr. Ozuah's ProfileMore coverage on Dr. Ozuah
Leukaemia Foundation MDS News - April 30, 2020
Ulrich Steidl, M.D., Ph.D., discusses his research on myelodysplastic syndromes (MDS) and acute myeloid leukemia (AML) and his hope that basic science and translational studies will lead to successful drug treatments for patients. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research and professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
November 21, 2018
Genetic Engineering & Biotechnology News quotes Ulrich Steidl, M.D., Ph.D., about his recent research on cancer stem cells that lead to myeloid leukemia. Dr. Steidl is the Diane and Arthur B. Belfer Faculty Scholar in Cancer Research, director of the Stem Cell Isolation and Xenotransplantation Facility and a professor of cell biology and of medicine at Einstein and associate chair for translational research in oncology at Montefiore.
Dr. Steidl's ProfileMore coverage on Dr. Steidl
January 6, 2015
Chemical & Engineering News highlights research by Peng Wu, Ph.D. and Ben Ovryn, Ph.D., who devised a way to track the movement of single glycoprotein molecules on the surfaces of living cancer cells. Dr. Wu is associate professor of biochemistry and Dr. Ovryn is associate professor of anatomy and structural biology.
Dr. Wu's Profile
February 5, 2013
Chemical & Engineering News interviews David Cowburn, Ph.D., about conflicting reports on the efficacy of stapled peptides, protein fragments chemically locked into an α-helical shape, and their potential for drug development. Dr. Cowburn, who has used stapled peptides to interfere with HIV assembly, notes that stapling is not easy and many adjustments need to be made to create a peptide that will work successfully within a cell. Dr. Cowburn is professor of biochemistry and of physiology & biophysics.
Dr. Cowburn's Profile
December 13, 2012
MedPage Today interviews Roy Chuck, M.D., Ph.D., about a study demonstrating a large increase in vision loss in the past decade, likely from diabetes. Dr. Chuck points out that vision loss in the young – those aged 22-39 – saw a significant increase, which is an indicator that damage to their eyes began when they were still children. Dr. Chuck is chair of ophthalmology & vision services at Einstein and Montefiore Medical Center.
Dr. Chuck's ProfileMore coverage on Dr. Chuck
October 24, 2012
Nature.com interviews Scott Emmons, Ph.D., about his study that determined the complete neural diagram that governs male roundworm mating behavior. Dr. Emmons notes that his lab took the unusual but important step of measuring the strength of each neural connection, instead of simply counting the number of synapses. Dr. Emmons is professor of genetics and in the Dominick P. Purpura Department of Neuroscience and the Siegfried Ullmann Chair in Molecular Genetics.
More CoverageDr. Emmons' ProfileMore coverage on Dr. Emmons
August 27, 2012
American Medical News interviews Robert Marion, M.D., about prenatal whole genome sequencing, which can identify an unborn child’s risk of developing chronic diseases. Because this new test will provide detailed information on mutations of 20,000 to 25,000 genes, some of which will not be significant, Dr. Marion stresses the importance of preparing healthcare professionals to counsel expectant parents about the results. Dr. Marion is director of Einstein’s Children's Evaluation and Rehabilitation Center and chief of developmental medicine at Einstein and Montefiore Medical Center.
Dr. Marion's ProfileMore coverage on Dr. Marion
April 25, 2012
The Journal of the National Cancer Institute interviews Geoffrey Kabat, Ph.D., on the difficulty of proving the link between bishpenol A (BPA), a common chemical in homes and food containers, and cancer risk. Dr. Kabat notes that politics can trump science when enormous public concern exists about an issue, particularly when it potentially effects infants, like BPA. Dr. Kabat is a senior epidemiologist at Einstein.
March 13, 2012
New Scientist interviews Vern Schramm, Ph.D., about his research on transition state analogs, a class of drugs he has been developing that target and neutralize specific enzymes in order to combat disease. Dr. Schramm is professor and Ruth Merns Chair in Biochemistry at Einstein.
Dr.Schramm's ProfileMore coverage on Dr.Schramm
February 1, 2012
Arthritis Today interviews Dr. Anna Broder regarding her research that found continued treatment may help extend the lives of lupus patients with end-stage renal disease. Dr. Broder is assistant professor of medicine.
Dr.Broder's ProfileMore coverage on Dr.Broder